• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

CSIS Report Finds Tech, Innovation Partnership Opportunities In Developing Countries

07/09/2017 by William New, Intellectual Property Watch Leave a Comment

“There are clear opportunities to accelerate and expand opportunity through innovation and technology around the world,” finds a new report from the Washington, DC-based Center for Strategic and International Studies (CSIS). And the United States – and any other developed country – would do well to position itself as a “partner of choice for developing countries that want to transform their economies through science, technology and innovation,” it said. But strong intellectual property rights and a business-friendly environment are a necessity, it argues.

Filed Under: Language, Subscribers, Themes, Venues, Development, English, Finance, Innovation/ R&D, Lobbying, North America, Regional Policy, Technical Cooperation/ Technology Transfer

Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure

24/08/2017 by Intellectual Property Watch 3 Comments

Fifa Rahman

Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WTO/TRIPS

Report From WHO Fair Pricing Meeting Shows Balanced Discussion

28/07/2017 by William New, Intellectual Property Watch Leave a Comment

A wide range of governments and stakeholders attended a closed meeting in the Netherlands in May to address the ongoing problem of pricing medicines to pay for research and the resulting lack of affordability of those medicines. The report from the World Health Organization-led meeting shows a range of points were made by participants and signals a move to change the global policy.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Companies Prefer Trade Secrets To Patents To Protect Innovation, EUIPO Finds

27/07/2017 by Dugie Standeford for Intellectual Property Watch 1 Comment

“Despite their economic importance, and in particular their role in protecting returns from innovation, trade secrets are poorly studied and their relationship with patents is often misinterpreted,” the EU Intellectual Property Office (EUIPO) said in a study published this month. It used a survey of around 200,000 companies in Europe’s manufacturing and service industries to determine what factors influenced their choice between patents and trade secrets, as well as their overall use of both mechanisms. The results could help policy-makers, the Office said. It also holds out opportunities for innovative lawyers and intellectual property firms, said one IP management consultant.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Europe, Finance, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

The Case For Nations To Act On Medicines Access

23/07/2017 by William New, Intellectual Property Watch 2 Comments

NEW YORK — A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead?

Filed Under: Features, IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO

WHO Prequalifies First Generic Hepatitis C Drug And First HIV Self-Test

21/07/2017 by William New, Intellectual Property Watch Leave a Comment

In the days before this month’s AIDS conference being held in Paris, the World Health Organization has announced the prequalification of the first generic version of sofosbuvir, a “critical” medicine for treating hepatitis C. Treatment for hepatitis C under patent has been notoriously priced at extreme high levels, putting it out of reach of patients in economies of all sizes.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Six Inconvenient Truths About NAFTA Renegotiations

21/07/2017 by Intellectual Property Watch 2 Comments

The renegotiation of the North American Free Trade Agreement’s (NAFTA’s) standards on patents is not good news for Canada. Any give by Canada will be costly not only to our health care system, but also to Canadian innovators, write Jean-Frédéric Morin and Richard Gold.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, English, Finance, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

WIPO Moves Slowly On Reduction In Compensation For Geneva-Based Staff

20/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

Earlier this year, the United Nations International Civil Service Commission called for a decrease in the compensation for the high cost of living for staff of Geneva-based United Nations agencies. At the World Intellectual Property Organization Program and Budget Committee last week, some countries asked why the decision was not reflected in the draft budget for 2018/2019. WIPO replied that discussions on the decision are ongoing among various agencies.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, English, Finance, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, United Nations - other, WIPO

WIPO Proposes 10 Percent Cut In Governments’ Annual Contributions

20/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

The World Intellectual Property Organization has proposed a 10 percent reduction in the contributions its member states make to the UN agency. The proposal, which met with some unanswered questions from WIPO member states at a committee meeting last week, is said to reflect the agency’s robust finances and will be taken up again in September. The move would shrink government contributions to WIPO’s overall budget to less than 5 percent of its total revenues.

Member states’ first reading of the proposed budget by WIPO for 2018/2019 also led to some amendments in programmes, notably new indicators of progress.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, English, Finance, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, United Nations - other, WIPO

WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030

17/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 102
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting